 |
 |
GEO help: Mouse over screen elements for information. |
|
| Status |
Public on Jul 02, 2013 |
| Title |
Lack of hepatic response of microRNA in mice following DB[a,h]A exposure (Agilent miRNA) |
| Organism |
Mus musculus |
| Experiment type |
Non-coding RNA profiling by array
|
| Summary |
Dibenzo[a,h]anthracene DB[a,h]A is a polycyclic aromatic hydrocarbon potent carcinogen. Few studies have investigated the role of DB[a,h]A on mRNA and miRNA expression. In this study a 10-week old male MutaTM Mouse were exposed to 6.25, 12.5, and 25 mg/kg/day DB[a,h]A by oral gavage for 28 consecutive days. DNA adducts were detected in the livers at each DB[a,h]A dose tested, and a dose-dependent increase in lacZ mutants was observed in the same samples. MAANOVA analysis revealed minor changes in the mRNA expression for the two lowest doses. Differential expression of 19 up-regulated and 22 down-regulated transcripts with fold-change > 1.5 (FDR-adjusted P < 0.05) were identified in the 6.25 mg/kg/day DB[a,h]A treatment group. For the 12.5 mg/kg/day treatment group 13 transcripts were up-regulated and 32 down-regulated (FDR-adjusted P < 0.05 and fold-change > 1.5). Major effect on mRNA expression resulted from exposure to the highest dose (25 mg/kg/day) of DB[a,h]A with 135 up-regulated and 104 down-regulated genes with fold-change > 1.5 (FDR-adjusted P < 0.05). The significantly regulated genes are involved in circadian rhythm, drug metabolism, glucose metabolism, cholestrol and lipid metabolism, immune response, cell cycle, and apoptosis. We also investigated miRNA response to the three doses of DB[a,h]A. MiRNA expression was relatively unaffected. Only miR-34a showed significant (FDR-adjusted P < 0.05) up-regulation with a fold change above 1.3-fold.
|
| |
|
| Overall design |
RNA samples from 5 control and 4-5 mice per treatment group (6.25mg/kg, 12.50mg/kg, and 25mg/kg) containing 100 ng were labelled using Agilent’s miRNA complete labelling and Hyb Kit (Agilent Tech, Mississauga, ON, Canada).
|
| |
|
| Contributor(s) |
Malik AI, Rowan-Carroll A, Williams A, Lemieux CL, White PA, Yauk CL |
| Citation(s) |
23793610 |
| |
| Submission date |
Jan 18, 2012 |
| Last update date |
Jul 02, 2013 |
| Contact name |
Andrew Williams |
| Organization name |
Health Canada
|
| Street address |
50 Columbine
|
| City |
Ottawa |
| State/province |
ON |
| ZIP/Postal code |
K1A OK9 |
| Country |
Canada |
| |
|
| Platforms (1) |
| GPL14972 |
Agilent-029152 Unrestricted Mouse miRNA v15.0 Microarray 028772 (miRBase release 15.0 miRNA ID version) |
|
| Samples (19)
|
| GSM863361 |
sample.6 12.50 mg/kg DB[a,h]A |
| GSM863362 |
sample.7 25 mg/kg DB[a,h]A |
| GSM863363 |
sample.8 25 mg/kg DB[a,h]A |
| GSM863364 |
sample.10 0 mg/kg DB[a,h]A |
| GSM863365 |
sample.11 6.25 mg/kg DB[a,h]A |
| GSM863366 |
sample.12 6.25 mg/kg DB[a,h]A |
| GSM863367 |
sample.14 12.50 mg/kg DB[a,h]A |
| GSM863368 |
sample.15 25 mg/kg DB[a,h]A |
| GSM863369 |
sample.16 25 mg/kg DB[a,h]A |
| GSM863370 |
sample.17 0 mg/kg DB[a,h]A |
| GSM863371 |
sample.18 6.25 mg/kg DB[a,h]A |
| GSM863372 |
sample.19 0 mg/kg DB[a,h]A |
| GSM863373 |
sample.20 12.50 mg/kg DB[a,h]A |
| GSM863374 |
sample.22 0 mg/kg DB[a,h]A |
| GSM863375 |
sample.23 25 mg/kg DB[a,h]A |
| GSM863376 |
sample.24 6.25 mg/kg DB[a,h]A |
|
| This SubSeries is part of SuperSeries: |
| GSE35509 |
Lack of hepatic response of microRNA in mice following DB[a,h]A exposure |
|
| Relations |
| BioProject |
PRJNA155965 |
| Supplementary file |
Size |
Download |
File type/resource |
| GSE35195_RAW.tar |
14.4 Mb |
(http)(custom) |
TAR (of TXT) |
| Processed data included within Sample table |
|
|
|
|
 |
Less...
More...